heliosDX‘s, a RushNet, Inc. subsidiary (OTCPINK: RSHN), interviews with Mr. Ashley Sweat, CEO, and Mr. Yann Gervill-Reache, COO

0
40

See the full episode at: https://newtothestreet.com/new-to-the-street-october-10-2021-heliosdx-b2b-digital-rego-payments-architectures-pharmagreen-biotech-paypolitan-globex-data-sekur-hapbee-technologies

New to The Street T.V. welcomes on this week’s show, RushNet, Inc. subsidiary (OTCPINK: RSHN), heliosDX’s Mr. Ashley Sweat, Chief Executive Officer, and Mr. Yann Gervill-Reache, Chief Operations Officer. Both Company’s executives talk, in-studio at NASDAQ, to the New to The Street T.V. host, Jane King, about heliosDX’s high complexity medical and drug testing lab. The focus remains comprehensive in providing patients and medical providers with a brand-name laboratory for testing alternatives with speed and accuracy to that of the big national lab. With a dedicated team at heliosDX, providing high-quality lab services with promptness and integrity, Mr. Sweat, CEO, explains the roadmap on corporate expectations for the next 15-month. He talks about a pending closing on a Reg A+ financing and explains the use-of-proceeds to grow themselves through further acquisitions. The Company’s objective is to become a national brand-name, recognizable lab facility. Mr. Yann Gervill-Reache, COO, gives the viewers an overview of what it will take for the Company to become a national lab and the numerous compliance strategies needed on state and federal levels.

To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/channel/UCceRKKS0QUfXlKUPBoxdTHQ

Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet
Follow New to the Street on Facebook: https://www.facebook.com/newtothestreet/
Follow New to the Street on Instagram: https://www.instagram.com/newtothestreettv/
Follow New to the Street on Rumble: https://rumble.com/user/newtothestreet
About New to the Street: https://newtothestreet.com/

Subscribe to our Mailing List: https://mailchi.mp/ccd21b3e3fab/join-our-mailing-list

LEAVE A REPLY

Please enter your comment!
Please enter your name here